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Background: Cytochrome P450 OleTJE from Jeotgalicoccus sp. ATCC 8456, a new member of the CYP152
peroxygenase family, was recently found to catalyze the unusual decarboxylation of long-chain fatty acids to form
α-alkenes using H2O2 as the sole electron and oxygen donor. Because aliphatic α-alkenes are important chemicals
that can be used as biofuels to replace fossil fuels, or for making lubricants, polymers and detergents, studies on
OleTJE fatty acid decarboxylase are significant and may lead to commercial production of biogenic α-alkenes in the
future, which are renewable and more environmentally friendly than petroleum-derived equivalents.
Results: We report the H2O2-independent activity of OleTJE for the first time. In the presence of NADPH and O2, this
P450 enzyme efficiently decarboxylates long-chain fatty acids (C12 to C20) in vitro when partnering with either the
fused P450 reductase domain RhFRED from Rhodococcus sp. or the separate flavodoxin/flavodoxin reductase from
Escherichia coli. In vivo, expression of OleTJE or OleTJE-RhFRED in different E. coli strains overproducing free fatty acids
resulted in production of variant levels of multiple α-alkenes, with a highest total hydrocarbon titer of 97.6 mg·l-1.
Conclusions: The discovery of the H2O2-independent activity of OleTJE not only raises a number of fundamental
questions on the monooxygenase-like mechanism of this peroxygenase, but also will direct the future metabolic
engineering work toward improvement of O2/redox partner(s)/NADPH for overproduction of α-alkenes by OleTJE.
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The urgency to develop sustainable fossil fuel alterna-
tives is driven by rapidly increasing global consumption,
irreversibly diminishing reserves, unpredictable geopolit-
ical factors, fluctuating price of crude oil, growing
concerns about national energy security, and serious en-
vironmental concerns surrounding immense greenhouse
gas emissions mainly resulting from combustion of fossil
fuels [1-3]. Biofuels produced from biological resources
represent a compelling alternative to fossil fuels because
they are renewable and more environmentally friendly
[4-7]. Among various biofuels, bioethanol and biodiesel
are dominating the current global market. However, it
is widely accepted that the ideal biofuels are bio-
hydrocarbons, especially the medium- to long-chain fatty* Correspondence: lishengying@qibebt.ac.cn
1Key Laboratory of Biofuels, Shandong Provincial Key Laboratory of Energy
Genetics, Qingdao Institute of Bioenergy and Bioprocess Technology,
Chinese Academy of Sciences, No. 189 Songling Road, Qingdao, Shandong
266101, China
Full list of author information is available at the end of the article
© 2014 Liu et al.; licensee BioMed Central Ltd.
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.alkanes or alkenes, because they highly mimic the chem-
ical composition and physical characteristics of petrol-
eum-based fuels [8-10]. Thus, the biosynthetic pathways
for aliphatic hydrocarbons from diverse organisms have
been attracting great attentions in recent years [11-13].
Particularly, the scalable and cost-effective microbial bio-
synthesis of fatty alkanes or alkenes is considered as one
of the most promising ways to produce ‘drop-in compat-
ible’ biofuels [5,8].
To date, four microbial biosynthetic pathways that
convert free fatty acids or fatty acid thioesters into
bio-hydrocarbons have been identified, including the
cyanobacterial pathways consisting of an acyl-acyl carrier
protein (acyl-ACP) reductase and an aldehyde decarbo-
nylase, which together convert fatty acyl-ACPs into
alkanes [14]; a three-gene cluster responsible for gener-
ating alkenes with internal double bonds through the
head-to-head condensation of two fatty acyl-coenzyme
A (acyl-CoA) molecules in Micrococcus luteus [15]; a
unique P450 decarboxylase OleTJE from Jeotgalicoccus
sp. ATCC 8456, which directly decarboxylates long-This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[16,17]; and a type I polyketide synthase from Synecho-
coccus sp. PCC 7002 [18,19], which is capable of trans-
forming fatty acyl-ACPs into α-olefins via sequential
polyketide synthase chain elongation, keto reduction,
sulfonation mediated by its sulfotransferase domain, and
the coupled hydrolysis and decarboxylation catalyzed by
the thioesterase domain.
Among these pathways, the single-step decarboxyl-
ation of fatty acids catalyzed by OleTJE P450 enzyme
[16] apparently represents the simplest one. Moreover, it
directly uses free fatty acids instead of fatty acid thioe-
sters as substrates, which is believed to be advantageous
for metabolic engineering because fatty acids are more
abundant and their abundance and composition can be
well manipulated in E. coli [20-22], one of the most de-
veloped microbial cell factories. Thus, this P450 fatty
acid decarboxylative machinery may hold great potential
to be engineered into a biological α-alkene-producing
system. Notably, in addition to being biofuel molecules,
α-alkenes are also used broadly for making lubricants,
polymers and detergents [17,23,24].
The superfamily of cytochrome P450 enzymes (CYPs)
are considered among the most versatile biocatalysts
in nature [25]. Typically, P450 enzymes employ one or
more redox partner proteins to transfer two electrons
from NAD(P)H to the heme iron reactive center for
dioxygen activation, and then insert one atom of O2 into
their substrates [25-27]. Therefore, these oxidative bioca-
talysts are often termed as P450 monooxygenases. How-
ever, the CYP152 family members such as P450SPα [28],
P450BSβ [29] and OleTJE [16] have been identified to ex-
clusively use H2O2 as the sole electron and oxygen
donor, and are thus classified into a unique P450 peroxy-
genase category.
Practically, the peroxygenase activity of P450 enzymes
is often treated as an advantageous feature because
H2O2 is much cheaper than NADPH and redox proteins
in many P450 applications such as biocatalysts for
in vitro synthetic reactions and enzyme additives in
laundry detergents [30,31]. However, the large-scale pro-
duction of low-cost α-alkene biofuels by OleTJE P450
decarboxylase cannot rely on the H2O2-dependent en-
zymatic system because the use of large amounts of per-
oxide is cost prohibitive, and high concentration of
H2O2 can quickly deactivate biocatalysts [32].
Therefore, the H2O2-independent activity of OleTJE, if it
exists, is preferred for cost-effective microbial production
of α-alkenes. In the present study, we demonstrated such
activity for the first time. Through engineering a self-
sufficient version of OleTJE by fusing it to the
Rhodococcus fusion reductase (RhFRED) domain from
Rhodococcus sp. NCIMB 9784 [33], the catalytic activity of
the resultant fusion P450 enzyme can be solely driven byNADPH. We also found that E. coli flavodoxin (Fld) and
flavodoxin reductase (FdR) are capable of supporting
OleTJE activity as well. Guided by these new findings, our
initial metabolic engineering efforts based on the H2O2-in-
dependent decarboxylation of fatty acids by OleTJE in vivo
led to a group of α-alkene overproducers with the best
one producing 97.6 mg·l-1 total α-alkenes.
Results
In vitro fatty acid decarboxylation by OleTJE and
OleTJE-RhFRED
The unusual activity of the first P450 fatty acid decarb-
oxylase OleTJE was determined by reconstituted in vitro
reactions [16]. Specifically, OleTJE was able to decarb-
oxylate stearic acid and palmitic acid to generate
1-heptadecene and 1-pentadecene, respectively, in the
presence of H2O2 (Figure 1A). It also catalyzed the
α- and β-hydroxylation of fatty acids as side reactions.
Using the purified P450 enzymes (Additional file 1:
Figure S1 and Additional file 2: Figure S2), we first con-
firmed these three types of activity of OleTJE using myr-
istic acid (C14) as substrate. Consistent with the previous
report [16], fatty acid decarboxylation was the dominant
reaction, while the α- and β-hydroxymyristic acid only
accounted for 0.2% and 6.1% of total products, respect-
ively (Figure 1B).
According to previous amino acid sequence analysis,
OleTJE was assigned to the CYP152 family, with the
well-studied P450BSβ [29,34,35] from Bacillus subtilis
and P450SPα [28,36] from Sphingomonas paucimobilis as
family members. Essentially, this family of P450 enzymes
utilizes H2O2 as the sole electron and oxygen donor to
oxidize their substrates, in contrast to most other P450
monooxygenases, whose catalytic activity depends on
dioxygen, NAD(P)H and redox partner protein(s) [37].
Thus, these P450 enzymes are functionally referred to as
peroxygenases [38]. Indeed, it was reported that P450
reductase systems such as ferredoxin and ferredoxin
reductase did not support the activity of P450BSβ and
P450SPα [36,39]. This is consistent with the substitution of
Pro246 and Arg245 (numbering in OleTJE) in CYP152 per-
oxygenases for the highly conserved threonine and an
acidic residue (for example, Glu or Asp) in most P450
monooxygenases (Additional file 3: Figure S3), which are
involved in a specific H-bond network responsible for de-
livery of protons during the P450 catalytic cycle [34,40].
However, in the study of another CYP152-member
P450CLA, from the anaerobic microorganism Clostridium
acetobutylicum [41], it was demonstrated that both
P450CLA and P450BSβ functioned when provided with O2,
NADPH and flavodoxin/flavodoxin reductase from E. coli
or the diflavin reductase domain of P450BM3 from Bacillus
megaterium, suggesting an alternative monooxygenase-
like mechanism of these P450 peroxygenases.
Figure 1 Decarboxylation and hydroxylation reactions catalyzed by OleTJE. (A) The decarboxylation and hydroxylation of fatty acids (C12 to C20)
catalyzed by OleTJE. (B) Product distribution of the decarboxylation and hydroxylation reactions catalyzed by purified OleTJE and OleTJE-RhFRED,
respectively. Myristic acid was used as substrate. 1-TE, 1-tridecene; α-OH MA, α-hydroxy myristic acid; β-OH MA, β-hydroxy myristic acid.
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function as a monooxygenase like P450CLA and P450BSβ,
the RhFRED reductase domain from Rhodococcus sp.
NCIMB 9784 [33] was fused to the C-terminus of OleTJE.
In the presence of the electron donor NADPH, the fusion
protein OleTJE-RhFRED successfully converted lauric acid
(C12) into 1-undecene with the conversion ratio of 51.1
±0.3%, approximately half that of OleTJE plus H2O2 (93.0
±4.3% conversion; Figure 2). Notably, the product distribu-
tion (decarboxylation versus hydroxylation) of the OleTJE-
RhFRED catalyzed reaction was similar to that of the
OleTJE reaction (Figure 1B), indicating the fused reductase
domain has no significant impact on the catalytic mechan-
ism of P450 domain. As control, OleTJE cannot directly use
NADPH as electron donor. OleTJE-RhFRED was not active
by itself. Interestingly, OleTJE-RhFRED retained its ability
to use H2O2 as a cofactor, but there was not a significant
additive effect between NADPH and H2O2 for supporting
the activity of OleTJE-RhFRED (Figure 2).
To prevent the spontaneous generation of H2O2 during
the OleTJE-RhFRED reaction, which could complicate inter-
pretation of the results, dithiothreitol (DTT: the reducing
agent often used in the storage and reaction buffer of P450
proteins) was omitted from all buffers used during protein
purification, storage and reaction because it has previously
been reported that DTT, dioxygen and the heme iron cen-
ter of P450 can react to generate H2O2 [16,42]. To further
exclude the possibility that H2O2 could be produced from
the peroxide shunt pathway during the monooxygenase
catalytic cycle [27], bovine liver catalase that is able to effi-
ciently eliminate H2O2 was added to the fatty acid decarb-
oxylation reactions (in the DTT-free buffer) catalyzed by
OleTJE and OleTJE-RhFRED. In the OleTJE plus H2O2
system, pre-addition of catalase completely abolished the
reaction (Figure 3). By contrast, in the OleTJE-RhFRED plus
NADPH reaction, pre-added catalase did not significantly
change (indeed, it slightly improved) the conversion ofmyristic acid to 1-tridecene (Figure 3). This clearly indicates
that the decarboxylation activity of OleTJE-RhFRED can be
solely supported by NADPH.
Substrate specificity of OleTJE and OleTJE-RhFRED
The substrate preference of OleTJE and OleTJE-RhFRED
provides useful information to help understand the in vivo
behavior of these fatty acid decarboxylases and to guide the
metabolic engineering of fatty acid biosynthesis. Thus, we
determined their substrate specificity (Figure 4) using a
number of straight-chain saturated fatty acids with even-
numbered chain length ranging from C8 to C20. In the case
of OleTJE (Figure 4A), myristic acid (C14) turned out to be
the best substrate for olefin production among the tested
fatty acids with the conversion ratio of 97.0 ± 2.8%. Lauric
acid (C12) and palmitic acid (C16) were sub-optimal. OleTJE
was only able to convert a minority of stearic acid (C18) and
arachidic acid (C20), but could not decarboxylate capric acid
(C10) or caprylic acid (C8).
In comparison, the substrate preference spectrum of
OleTJE-RhFRED slightly shifted toward shorter fatty acids
(Figure 4B), which suggests that the P450-reductase inter-
action might induce small conformational change of the
OleTJE active site. Specifically, OleTJE-RhFRED showed the
highest activity against lauric acid (83.8 ±0.1% conversion),
but was inactive toward arachidic acid. Similar to OleTJE,
OleTJE-RhFRED could not decarboxylate capric acid or
caprylic acid. It is also worth noting that the system of
OleTJE-RhFRED plus NADPH plus O2 was less active than
OleTJE plus H2O2 when reacting with most tested fatty acids
except for lauric acid, suggesting OleTJE might have evolved
to become a better peroxygenase than a monooxygenase.
In vivo production of α-alkenes in Escherichia coli
Motivated by the efficient in vitro conversion of free fatty
acids (Cn) to corresponding α-alkenes (Cn-1) by two re-











































































































Figure 2 Gas chromatography-mass spectroscopy analysis of decarboxylation reactions (10 min) catalyzed by OleTJE or OleTJE-RhFRED
under different reaction systems. (A) OleTJE + H2O2; (B) OleTJE + NADPH; (C) OleTJE-RhFRED + NADPH; (D) OleTJE-RhFRED + H2O2; (E) OleTJE-
RhFRED + NADPH + H2O2; (F) OleTJE-RhFRED in absence of NADPH; (G) authentic standards of 1-undecene (U) lauric acid (LA) and heptadecanoic
acid (IS: internal standard).
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NADPH plus O2, we sought to engineer hydrocarbon-
producing strains of E. coli. To guarantee sufficient
substrate supply of free fatty acids for OleTJE P450
decarboxylase, two previously engineered fatty acid-
overproducing strains including XL100 (BL21:ΔfadD) and
XL100/(pMSD8 + pMSD15) [43] were used as hosts for
the decarboxylases. Transformation of these two strains
with pET28b-oleTJE or pET28b-oleTJE-RhFRED resulted in
YL5 (XL100 with pET28b-oleTJE), YL6 (XL100 with
pET28b-oleTJE-RhFRED), YL7 (XL100 with pET28b-
oleTJE, pMSD8 and pMSD15), and YL8 (XL100 with
pET28b-oleTJE-RhFRED, pMSD8 and pMSD15) (Table 1).As expected, all these engineered strains successfully
accumulated multiple α-alkenes, including 1-tridecene,
trideca-1,6-diene, 1-pentadecene, pentadecene-1,8-diene
and heptadeca-1,10-diene (Figure 5A and Additional file
4: Figure S4), which correspond to the decarboxylation
products of the 14:0, 14:1, 16:0, 16:1 and 18:1 fatty acids,
respectively. This fatty acid composition is consistent
with previous reports [43]. In all cases, the major alkene
product was heptadeca-1,10-diene with the highest yield
of 7.7 mg·l-1 in YL7. Since XL100/(pMSD8 + pMSD15)
is able to produce more free fatty acids than XL100 [43],
the total alkene titers of YL7 and YL8 were significantly
greater than those of YL5 and YL6. Notably, expression
Figure 3 Effects of catalase on the in vitro decarboxylation activity of three OleTJE (1 μM) reaction systems. Systems comprised OleTJE
plus H2O2, OleTJE-RhFRED plus NADPH, and OleTJE plus flavodoxin and flavodoxin reductase plus NADPH. The percentage conversion of
myristic acid is shown beside each bar.
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cell growth of all strains (Additional file 5: Figure S5).
According to a previous report [44], H2O2 levels in
growing E. coli are less than 20 nM, and 2 μM H2O2
could cause substantial growth inhibition. Therefore, the
physiological concentration of H2O2 is far below the
optimal H2O2 concentration (200 to 500 μM) [16] for
supporting OleTJE catalysis. Thus, we had predicted
that OleTJE-RhFRED using endogenous NADPH, whose
physiological concentration is around 120 μM [45],
might catalyze the decarboxylation more efficiently than
OleTJE using H2O2 as a cofactor. Unexpectedly, the
highest titer (11.8 mg·l-1) and productivity (4.5 mg·g
dcw-1) of total alkenes was achieved by YL7 with OleTJE
instead of YL8 with OleTJE-RhFRED. This contradiction
has led to a hypothesis that OleTJE is able to employ theFigure 4 Substrate preference spectrum of (A) OleTJE and (B) OleTJE-R
percentage conversion of each fatty acid substrate into corresponding α-alnative redox system of E. coli to drive catalysis, such as
P450CLA and P450BSβ [41].
To test this hypothesis, we expressed and purified the
E. coli Fld and FdR. In the in vitro reaction containing
OleTJE, Fld, FdR and NADPH, myristic acid was sub-
stantially converted into 1-tridecene (Figure 3). There-
fore, Fld and FdR probably better serve OleTJE than the
fused RhFRED in vivo, explaining why YL7 was a better
alkene producer than YL8. However, the supportive role
of H2O2 cannot be entirely neglected.
Inspired by these results, we attempted to enhance the
level of dissolving dioxygen for improving OleTJE cataly-
sis during the cultivation of the best alkene producer,
YL7, by applying a higher rotation rate of 250 rpm. More-
over, the defined mineral medium [14] containing 3% glu-
cose was used to standardize the culture condition forhFRED. The substrate preference was determined by calculating the
kene product. In these assays, 0.2 μM enzymes were used.
Table 1 Strains and plasmids used in this study
Strain or
plasmid
Relevant characteristics Source or
reference
E. coli strains





DH5α F- ξ80lacZΔM15 Δ (ΔlacZYA-argF)
U169 recA1 endA1 hsdR17 (rk-, mk+)
phoA supE44 thi-1 gyrA96 relA1 λ-
Invitrogen
XL100 BL21: ΔfadDa [43]
YL1 BL21(DE3) with pET28b-oleTJE This study
YL2 BL21(DE3) with pET28b-oleTJE-RhFRED This study
YL3 BL21(DE3) with pACYCDuet-fdR This study
YL4 BL21(DE3) with pCDEDuet-fld This study
YL5 XL100 with pET28b-oleTJE This study
YL6 XL100 with pET28b-oleTJE-RhFRED This study











pET28b Kmr, T7 promoter, pBR322 origin Novagen
pET28b-oleTJE Km





Kmr, pET28b derivative containing
oleTJE and RhFRED gene
This study
pACYCDuet-1 Cmr, T7 promoter, P15A origin Novagen
pACYCDuet-fdR Cmr, pACYCDuet-1 derivative
containing fdR gene
This study
pCDFDuet-1 Strr, T7 promoter, CloDF13 origin Novagen
pCDEDuet-fld Strr, pCDFDuet-1 derivative
containing fld gene
This study
pMSD8 Ampr, PT7: accB, C, D, A,
pSC101 origin
[43]
pMSD15 Cmr, PBAD: tesA, p15a origin [43]
aThe fadD gene encodes the acyl-CoA synthetase, which is the first enzyme
involved in fatty acid degradation. bpMSD8: the expression vector for E. coli
acyl-CoA carboxylase. cpMSD15: the plasmid used for overexpression of the E.
coli thioesterase gene tesA. Amp, ampicillin; Cm, chloramphenicol; Km,
kanamycin; Str, streptomycin.
Liu et al. Biotechnology for Biofuels 2014, 7:28 Page 6 of 12
http://www.biotechnologyforbiofuels.com/content/7/1/28the future metabolic engineering, and the culture time
was extended to 40 h. Significantly, the total alkene titer of
YL7 under these conditions was 97.6 mg·l-1 (Figure 5B),
which is almost seven-fold higher than that in lysogeny
broth (LB) medium at 220 rpm for 20 h (Figure 5A). The
productivity of total alkenes was also improved from 4.5
mg·g dcw-1 (in LB over 20 h) to 24.9 mg·g dcw-1 (in the
defined mineral medium over 40 h, data not shown).
Again, heptadeca-1,10-diene was the major alkene product
(41.4 mg·l-1). As control, the production of free fatty acids
by the strain XL100/(pMSD8 + pMSD15) without OleTJEexpression was evaluated. Octadec-11-enoic acid was
the most abundant fatty acid with a titer of 96.1 mg·l-1
(Additional file 6: Figure S6). This well explains why its
decarboxylated product, heptadeca-1,10-diene, had the
highest yield among produced alkenes (Figure 5). With re-
spect to fatty acid conversion, octadec-11-enoic acid had
the highest conversion ratio (85.9%) followed by hexadec-
9-enoic acid (85.7%), myristic acid (75.7%), palmitic acid
(74.0%) and lauric acid (24.4%). The low conversion of lau-
ric acid seems to be inconsistent with the in vitro result
(Figure 4A), which is likely due to the low intracellular
concentration of the C12 fatty acid.
Discussion
The cytochrome P450 enzymes are a superfamily of
b-type heme proteins, capable of catalyzing more than
20 different types of reactions [25,46,47]. The H2O2-
assisted decarboxylation of long-chain fatty acids cata-
lyzed by P450 OleTJE represents a novel activity of this
highly versatile superfamily. This activity may be mech-
anistically similar to that of P450Rm (CYP53B) from the
yeast Rhodotorula minuta [48], which decarboxylates
isovalerate to form isobutene.
According to protein sequence alignment (Additional
file 3: Figure S3), OleTJE belongs to the CYP152 peroxy-
genase family together with the well-studied P450BSβ
and P450SPα [28,29], and other members. Functionally,
these P450 peroxygenases were previously thought to
have no ability of utilizing dioxygen to drive catalysis as
typical P450 monooxygenases do [39]. However, we have
unambiguously demonstrated that OleTJE can perform
H2O2-independent catalysis when partnering with the
fused RhFRED reductase or the E. coli Fld/FdR system
to transfer electrons from NADPH to the heme iron
reactive center. This strongly suggests that OleTJE
can undergo the monooxygenase catalytic cycle to
generate the highly reactive ferryl-oxo cation radical spe-
cies (Compound I) for catalysis. In the well-accepted
mechanism for dioxygen activation in P450 monooxy-
genases (Figure 6), two protons (and two electrons from
NADPH) are required for generation of Compound I
[27]. However, the conserved threonine and an acidic resi-
due involved in proton delivery in normal P450 monooxy-
genases [34,40] are replaced by Pro and Arg, respectively,
which are absolutely conserved in OleTJE and all other
known CYP152 family members (Additional file 3: Figure
S3). This strongly suggests an unknown proton transfer
pathway. To elucidate this hypothetical pathway, we are
currently seeking to solve the crystal structure of OleTJE.
Evolutionarily, because the early Earth’s environment
probably had more H2O2 and peroxygenated organic
chemicals than O2, P450 peroxygenases are presumed to
have emerged ahead of P450 monooxygenases [38].
Thus, the ability of most P450 monooxygenases to use
Figure 5 Production of α-alkenes by heterologous expression of OleTJE or OleTJE-RhFRED in fatty acid-overproducing Escherichia coli
strains. (A) Production of α-alkenes by OleTJE and OleTJE-RhFRED in two fatty acid-overproducing E. coli strains. The line chart denotes the alkene
productivity. (B) The α-alkene production and fatty acid conversion profiles of strain YL7 in the defined mineral medium. The histograms demonstrate
the titer of each detected α-alkene titers. The line chart demonstrates the conversion ratio of corresponding fatty acids. FFA, free fatty acid.
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-/2H+ system (perox-
ide shunt pathway, Figure 6) could be understood as a
remnant function inherited from their peroxygenase an-
cestors, whereas the OleTJE P450 peroxygenase bearing
the monooxygenase property might represent a transi-
tion species during the evolving process from peroxy-
genase to monooxygenase.
Under certain circumstances, such as in vitro synthetic
reactions using purified P450s and application of P450
enzymes in laundry detergents, the peroxygenase activity
supported by H2O2 is advantageous because expensive
redox partner proteins and NAD(P)H are not neededFigure 6 Proposed two alternative catalytic mechanisms of OleTJE with (m
The Arg245 is proposed to be required for substrate anchoring via the strong ele
The supply of two protons in the putative monooxygenase catalytic cycle rema[30,31]. However, the peroxygenase nature is not a good
feature if attempting to construct a biofuel-producing
microorganism by taking advantage of the fatty acid
decarboxylation activity of OleTJE. Essentially, the intra-
cellular level of H2O2 cannot be increased to the con-
centration (101 to 102 μM range) required for efficiently
supporting OleTJE because at this level, H2O2 is toxic or
fatal to all organisms including E. coli. Thus, that the ac-
tivity of P450 OleTJE can be supported by O2/redox part-
ner(s)/NADPH besides H2O2 is a significant discovery
because the former three factors are more viable targets
for metabolic engineering [49-51]. Being aware of this,onooxygenase-like) or without (peroxygenase-like) redox systems.
ctrostatic interactions with the carboxyl group of fatty acid substrate.
ins unclear. The dashed arrow indicates the peroxide shunt pathway.
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the in vivo productivity of α-alkenes by OleTJE probably
should be directed to improvement of the intracellular
level of dioxygen, redox partner protein(s) and/or
NADPH. For example, among numerous metabolic
strategies for in vivo up-regulation of NADPH [49], the
NADPH regenerating system could be used for main-
taining the high intracellular level of this reducing cofac-
tor to better support the activity of OleTJE and the
overproduction of fatty acids [52,53], both of which re-
quire a sufficient supply of NADPH.
In the mutant E. coli strains with up-regulated fatty acid
biosynthesis (XL100 and XL100/(pMSD8 + pMSD15)),
both OleTJE and OleTJE-RhFRED were functional, there-
fore significantly converting fatty acids into α-alkenes.
Consistent with the previous report [16], the common
major product of four engineered alkene producers (YL5-
8) turned out to be heptadeca-1,10-diene, but the second
most abundant alkene varied (Figure 5A). This is likely be-
cause octadec-11-enoic acid (the precursor of heptadeca-
1,10-diene) was the predominant component of the fatty
acid pool of the tested strains (Additional file 6: Figure
S6). However, there might be an additional reason that
octadec-11-enoic acid is a preferred substrate in vivo.
Interestingly, in previous studies [43,54,55], palmitic acid
rather than octadec-11-enoic acid was the major compo-
nent in the fatty acid pool of E. coli. This inconsistency
could be due to different culture conditions.
After 20 h cultures of YL7 in LB medium, significant
amounts of fatty acids remained unreacted with OleTJE
(Additional file 4: Figure S4). By contrast, the majority of
fatty acids in YL7 were consumed by OleTJE over the
longer and more oxygenated cultivation in the defined
mineral medium (Figure 5B). This suggests that, at the
current stage, the yield of fatty acids might be the major
limiting factor for further improvement of α-alkene
titers. Thus, the overproduction of fatty acids needs to
be significantly optimized prior to other engineering ef-
forts on up-regulating the level of OleTJE, redox part-
ners, O2 and NADPH.
In this report, the best bio-hydrocarbon-producing
strain YL7 accumulated 97.6 mg·l-1 of total alkenes. This
yield is comparable to or better than a majority of engi-
neered alkane and alkene biosynthetic pathways with
reported yields. These include the artificial alkane bio-
synthetic pathway in E. coli consisting of the carboxylic
acid reductase from Mycobacterium marinum that cata-
lyzes formation of fatty aldehydes directly from fatty
acids, and the aldehyde decarbonylase from Synechocys-
tis sp. PCC 6803 to produce alkanes (yield: approxi-
mately 2 mg·l-1) [56]; the hybrid system using the fatty
acid reductase complex (LuxC, LuxE and LuxD) to
provide fatty aldehyde as the substrate for downstream
aldehyde decarbonylase to generate alkanes (yield: ap-proximately 2 to 5 mg·l-1) [20]; and the ATP required
decarboxylation of 3-hydroxy-3-methylbutyrate catalyzed
by the R74H mutant of mevalonate diphosphate decarb-
oxylase from Saccharomyces cerevisiae (productivity: 5,888
pmol·h-1·g cells-1) [57]. It is only lower than the 300 mg·l-1
of total alkane titer produced when the cyanobacterial
pathway consisting of the acyl-ACP reductase Orf1594
from Synechococcus elongates PCC7942 and the aldehyde
decarbonylase from Nostoc punctiforme PCC73102 was
heterologously expressed in E. coli [14]. However, it is
expected that more metabolic engineering efforts and
optimization of fermentation will further increase the total
alkene titers of the OleTJE/E. coli system, which is cur-
rently ongoing in our laboratory.
Conclusions
The H2O2 independence of OleTJE described in this
work not only raises a number of fundamental questions
regarding its monooxygenase-like mechanism, but also
could direct future metabolic engineering work toward
improvement of O2/redox partner(s)/NADPH for opti-
mal activity of OleTJE in vivo. Considering its high con-
version rate in vitro and H2O2-independent functionality
in vivo, it is of great potential for engineering a hyper-
producer of α-alkenes on the basis of OleTJE.
Methods
Materials
Fatty acid substrates, terminal alkene authentic standards,
and derivatizing reagents were purchased from TCI
(Shanghai, China). Antibiotics were obtained from Solar-
Bio (Beijing, China). Other chemicals were from Sigma
Aldrich (St. Louis, MO, USA) or Ameresco (Solon, OH,
USA). Oligonucleotides were synthesized by Sangon Bio-
tech (Shanghai, China), and their sequences are shown in
Additional file 7: Table S1. The Pfu DNA polymerases and
all restriction endonucleases were obtained from Fermen-
tas (Vilnius, Lithuania) or Takara (Dalian, China). The kits
used for molecular cloning were from OMEGA Bio-Tek
(Jinan, China) or Promega (Madison, WI, USA). Protein
purification used Qiagen Ni-NTA resin (Valencia, CA,
USA), Millipore Amicon Ultra centrifugal fliters (Billerica,
MA, USA) and PD-10 desalting columns from GE Health-
care (Piscataway, NJ, USA). Bovine liver catalase was pur-
chased from Sigma Aldrich.
Molecular cloning
Strains and plasmids constructed and used in this study
are listed in Table 1. The gene of oleTJE was amplified
from the genomic DNA of Jeotgalicoccus sp. ATCC
8456 using the primer pair of OleT-NdeI/OleT-HindIII
(Table 1). The gel-cleaned PCR fragment was double
digested by NdeI and HindIII and subsequently ligated
into the NdeI/HindIII pre-treated pET28b to afford
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pET28b-oleTJE-RhFRED, the genes of oleTJE and
RhFRED were first fused by overlap extension PCR [58].
Briefly, the gene encoding RhFRED reductase was ampli-
fied from the previously constructed pET28b-pikC-
RhFRED [59,60] with a pair of primers including
RhFRED-F and RhFRED-R. The oleTJE gene was ampli-
fied from pET28b-oleTJE, using the primers OleT-F and
OleT-RhFRED-OE. Then the two PCR fragments with
overlap sequence were mixed, annealed, extended and fi-
nally amplified with the OleT-F/RhFRED-R primer pair,
giving rise to the fused gene of oleTJE-RhFRED. This fu-
sion product was digested by NdeI/HindIII and inserted
into the NdeI/HindIII-digested pET28b to generate
pET28b-oleTJE-RhFRED (Additional file 8: Figure S7B).
Using the genomic DNA of E. coli DH5α as template,
the two genes encoding Fld and FdR were amplified with
the primer pairs of Fld-BamHI-F/Fld-SalI-R and FdR-
BamHI-F/FdR-SalI-R, respectively. Next, the fld and fdR
genes were sub-cloned into pACYCDuet-1 and
pCDFDuet-1 respectively, resulting in pACYCDuet-fld
and pCDFDuet-fdR. All sub-cloned sequences were
confirmed by DNA sequencing at Sangon Biotech,
Shanghai.
Protein overexpression and purification
The E. coli BL21(DE3) cells carrying the recombinant
expression vector were grown at 37°C for 16 to 20 h
in LB medium containing certain selective antibiotics
(50 μg·ml-1 kanamycin, 34 μg·ml-1 chloramphenicol, or
50 μg·ml-1 streptomycin), which were used to inoculate
(1:100 ratio) Terrific Broth medium containing corre-
sponding antibiotics, thiamine (1 mM), 10% glycerol and
a rare salt solution [61]. Cells were grown at 37°C for
3 to 4 h until the optical density at 600 nm (OD600)
reached 0.6 to 0.8, at which isopropyl-β-D-thiogalactopy-
ranoside (IPTG, 0.2 mM as final concentration) and
δ-aminolevulinic acid (0.5 mM, only for P450 expression)
were added, followed by 18 h of cultivation at 18°C.
Protein purification was carried out as described else-
where [61] with slight modifications. Specifically, the
cell pellets harvested by centrifugation (5,000 × g, 4°C,
15 min) were stored at −80°C and melted at ambient
temperature immediately before use. Then the cell
pellets were resuspended in 40 ml of pre-chilled lysis
buffer (pH 8.0, 50 mM NaH2PO4, 300 mM NaCl, 10%
glycerol and 10 mM imidazole) through vortexing.
Following a sonication step, the cell lysate was centri-
fuged at 12,000 × g for 30 min to remove the insoluble
fraction. To the supernatant, 1 ml of Ni-NTA resin
was added and gently mixed at 4°C for 1 h. The slurry
was loaded onto an empty column, and washed with
approximately 100 ml of wash buffer (pH 8.0, 50 mM
NaH2PO4, 300 mM NaCl, 10% glycerol and 20 mMimidazole) until no proteins were detectable in flow-
through. The bound target proteins were eluted with
elution buffer (pH 8.0, 50 mM NaH2PO4, 300 mM NaCl,
10% glycerol and 250 mM imidazole). The eluent was
concentrated with an Amicon Ultra centrifugal filter,
and buffer exchanged on a PD-10 desalting column. Fi-
nally, the desalted purified proteins (Additional file 1:
Figure S1) in storage buffer (pH 7.4, 50 mM NaH2PO4,
10% glycerol) were flash-frozen by liquid nitrogen and
stored at −80°C for later use.
Determination of protein concentration
Following the method described by Omura and Sato [62],
the CO-bound reduced difference spectrum (Additional
file 2: Figure S2) of each P450 enzyme was recorded on a
UV-visible spectrophotometer DU 800 (Beckman Coulter,
Fullerton, CA, USA). The functional P450 concentration
was calculated using the extinction coefficient (ϵ450–490)
of 91,000 M-1·cm-1. The concentration of Fld and FdR
from E. coli was determined using ϵ579 = 4,570 M
-1·cm-1
[63] and ϵ456 = 7,100 M
-1·cm-1 [64], respectively.
In vitro enzymatic assays with purified proteins
The fatty acid decarboxylation assays containing 0.2 to
1.0 μM OleTJE or OleTJE-RhFRED, 200 μM fatty acid
substrate (from C8 to C20), 500 μM H2O2 (for OleTJE) or
500 μM NADPH (for OleTJE-RhFRED) in 200 μl of stor-
age buffer were carried out at 28°C for 2 h. In the assay
to test whether E. coli Fld and FdR are able to support
the activity of OleTJE, 5 μM Fld and 5 μM FdR were
mixed with 200 μM myristic acid, 500 μM NADPH and
1 μM OleTJE in 200 μl of storage buffer. To remove
spontaneously generated H2O2, bovine liver catalase was
added to the final concentration of 20 U·ml-1.
All above described reactions were quenched by addi-
tion of 20 μl of 10 M HCl. Heptadecanoic acid was added
as internal standard and the mixture was extracted by 200
μl ethyl acetate. Samples were then analyzed by gas
chromatography-mass spectroscopy (GC-MS; see below).
In vivo production of α-alkenes
The E. coli fadD deletion mutant strain XL100 [43] that
overproduces fatty acids was selected as the starting host
for construction of alkene-producing strains. Plasmids
pMSD8 and pMSD15 were gifts from Dr. John Cronan
and were used in the strain XL100 to construct fatty
acid-overproducing strains. Bacterial cells transformed
with certain plasmid(s) (Table 1) were either grown in
50 ml of LB medium or in 50 ml of defined mineral
medium [14] containing 3% glucose as the carbon
source, supplemented with appropriate selective antibi-
otics, thiamine (1 mM) and a rare salt solution. All culti-
vations were performed at 37°C and induced at an
OD600 of 0.9 to 1.0 with 0.4% arabinose (for pMSD15)
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oleTJE or pET28b-oleTJE-RhFRED) after 0.5 h. Next, cells
were grown at 28°C (the optimal temperature for OleTJE
expression) for an additional 20 h at 220 rpm (in LB
medium) or 40 h at 250 rpm (in the defined mineral
medium). For analysis of hydrocarbon production, 20 ml
of culture with 10 μl heptadecanoic acid added as
internal standard was sonicated for 10 min and then
thoroughly mixed with an equal volume of chloroform-
methanol (2:1, vol/vol). The aqueous-organic mixture
was centrifuged (8,000 × g for 15 min) for phase separ-
ation. The organic phase was transferred into a clean
tube, evaporated under a nitrogen flow, and re-dissolved
in 500 μl of n-hexane as the testing sample. Prior to
GC-MS analysis, 5 μl eicosane was added as calibration
standard. All experiments were repeated two to four
times.
Analytical methods
The GC-MS analytical method for hydrocarbon and
fatty acid samples was adapted from Guan et al. [65].
The analyses were performed on an Agilent 7890A gas
chromatograph equipped with a capillary column HP-
INNOWAX (Agilent Technologies, Santa Clara, CA,
USA; cross-linked polyethylene glycerol, i.d. 0.25 μm
film thickness, 30 m by 0.25 mm) coupled to an Agilent
5975C MSD single quadrupole mass spectrometer oper-
ated under electron ionization mode at 70 eV in the scan
range of 50 to 500 m/z. The helium flow rate was set to
1 ml·min-1. The oven temperature was controlled ini-
tially at 40°C for 4 min, then increased at the rate of
10°C per min to 250°C, and held for 15 min. The inject-
ing temperature was set to 280°C with the injection vol-
ume of 1 μl under splitless injection conditions. Under
these conditions, the previously reported thermal degra-
dations of α- and β-hydroxy fatty acids to form alkenes
(the minor products of OleTJE catalyzed reaction) in
the GC inlet [16] were not observed (Additional file 9:
Figure S8), making the silylating protection of the
hydroxyl group unnecessary if only caring about the
α-alkene products. To detect α- and β-hydroxy fatty
acids, samples were derivatized with an equal volume of
N, O-bis(trimethylsilyl)trifluoroacetamide with 1% tri-
methylchlorosilane at 70°C for 15 min. GC-MS analysis
followed the previous protocol developed by Rude et al.
[16] except for using the Agilent J&W DB-5 MS column
(i.d. 0.25 μm film thickness, 50 m by 0.25 mm). During
GC-MS analysis, peak identity was determined by com-
parison of retention time and fragmentation pattern
with authentic standard compounds where available
and to the National Institute of Standards and Technol-
ogy, USA mass spectral database. The location of double
bond(s) in α-olefins was deduced by derivatization
with dimethyl disulfide as described previously [66].Quantification was achieved by comparison of integrated
peak areas with calibration curves of authentic standards.
The conversion percentages of free fatty acids to corre-
sponding α-alkenes were estimated using the equation:
[total alkenes]/([total alkenes] + [total free fatty acids]).Additional files
Additional file 1: Figure S1. SDS-PAGE analysis of purified (A) OleTJE
and (B) OleTJE-RhFRED. M, protein marker.
Additional file 2: Figure S2. CO-bound reduced spectra of purified (A)
OleTJE and (B) OleTJE-RhFRED.
Additional file 3: Figure S3. Protein sequence alignment of CYP152
family members and three selected P450 monooxygenases. Protein
sequences were obtained from NCBI protein databases. CYP152A1
(P450BSβ from Bacillus subtilis); CYP152A2 (P450CLA from Clostridium
acetobutylicum); CYP152B1 (P450SPα from Sphingomonas paucimobilis);
CYP152B2 (from Azotobacter vinelandii); CYP152C1 (from Rhodobacter
sphaeroides); CYP152C2 (from Rhodobacter sphaeroides); CYP152D1 (from
Streptomyces scabies); CYP152E1 (from Cyanothece sp. CCY0110);
CYP107L1 (P450PikC from Streptomyces venezuelae); CYP102A1 (P450BM3
from Bacillus megaterium); CYP101A1 (P450cam from Pseudomonas putida).
Conserved amino acid residues are shaded. The Arg and Pro absolutely
conserved in CYP152 family are marked by asterisks.
Additional file 4: Figure S4. GC-MS analysis of the organic extract of
the YL7 culture in LB broth. Eicosane and heptadecanoic acid are served
as calibration standard (CS) and internal standard (IS), respectively.
Additional file 5: Figure S5. The dry cell weight of the YL5-8 cultures
using LB broth.
Additional file 6: Figure S6. Production profile of free fatty acids by
the strain XL100/(pMSD8 + pMSD15).
Additional file 7: Table S1. Primers used in this study.
Additional file 8: Figure S7. Plasmid maps for (A) pET28b-oleTJE and
(B) pET28b-oleTJE-RhFRED expression vectors.
Additional file 9: Figure S8. GC-MS analysis of the α- and β-hydroxy
myristic acid authentic standards on HP-INNOWAX capillary column.
(A) Without derivatization, α-hydroxy myristic acid was unseen due to its
high boiling point. Importantly, no thermally degraded terminal olefin
(1-tridecene) was observed in the dashed box. (B) Without derivatization,
β-hydroxy myristic acid was unseen due to its high boiling point. Again,
no thermally degraded terminal olefin (1-tridecene) was observed in
the dashed box. (C) The decarboxylation reaction of myristic acid (2 h)
catalyzed by OleTJE. The peak shown in the dashed box corresponds
to 1-tridecene.Abbreviations
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